Background:: Angiopoietin-like 4 (ANGPTL4) belongs to the angiopoietin-like protein family and mediates the inhibition of lipoprotein lipase activity. Emerging evidence suggests that ANGPTL4 has pleiotropic functions with anti- and pro-inflammatory properties. Methods:: A thorough search on PubMed related to ANGPTL4 and inflammation was performed. Results:: Genetic inactivation of ANGPTL4 can significantly reduce the risk of developing coronary artery disease and diabetes. However, antibodies against ANGPTL4 result in several undesirable effects in mice or monkeys, such as lymphadenopathy and ascites. Based on the research progress on ANGPTL4, we systematically discussed the dual role of ANGPTL4 in inflammation and inflammatory diseases (lung injury, pancreatitis, heart diseases, gastrointestinal diseases, skin diseases, metabolism, periodontitis, and osteolytic diseases). This may be attributed to several factors, including post-translational modification, cleavage and oligomerization, and subcellular localization. Conclusion:: Understanding the potential underlying mechanisms of ANGPTL4 in inflammation in different tissues and diseases will aid in drug discovery and treatment development.
CITATION STYLE
Zuo, Y., He, Z., Chen, Y., & Dai, L. (2023, June 1). Dual role of ANGPTL4 in inflammation. Inflammation Research. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00011-023-01753-9
Mendeley helps you to discover research relevant for your work.